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Introduction
Tissue-engineered (TEng) valves have recently been devel-
oped as an alternative to pulmonary valve replacement
with homograft conduits to improve device life-time and
function.
Purpose
To evaluate with advanced CMR techniques the morpho-
logical and functional properties of a decellularized por-
cine xenograft valve conduit (Matrix-P™) and its successor
product with additional equine pericardium sheathing
(Matrix-P-Plus™; AutoTissue, Germany).
Methods
TEng valves had been implanted into the right ventricular
outflow tract of 12 pts (age: 15 ± 8,5 yrs; Matrix-P™ n = 7;
Matrix-P-Plus™ n = 5) due to pulmonary stenosis or insuf-
ficiency within a median 5 months range (2-7 months)
before a comprehensive follow-up by CMR. Echocardiog-
raphy was suspicious of accelerated blood flow in the
main pulmonary artery in 10 of those. The severity of the
pulmonary valve stenosis was assessed by gradient echo
cine MRI (FOV 270 × 270 mm, voxel size 1.88 × 1.94 × 5
mm, TR/TE/α = 4.4 ms/2.7 ms/15°) and phase-contrast
velocity mapping (FOV 270 × 270 mm, voxel size 1.64 ×
1.4 × 7 mm, TR/TE/α = 15 ms/2.5 ms/30°, velocity encod-
ing (VENC) = 400 cm/s) were applied. For tissue charac-
terisation late enhancement imaging (Gd 0.1 mmol/kg)
using an ECG triggered 3D inversion recovery sequence
(TR/TE/α= 3.7 ms/1.8 ms/15°; voxel size 1.17 × 1.27 × 10
mm) and T1 and T2 weighted turbo spin echo sequences
were utilized.
Results
In 9 pts (33%) CMR detected a significant conduit steno-
sis (Vmax 3.7 ± 1,3 m/s) with mild or moderate insuffi-
ciency (RGF 21.3 ± 5.9%) post-surgery. In 3 pts the
conduit was considered to be normal. In all pts with a ste-
nosis, T1-weighted images showed significant paravalvu-
lar Gadolinium enhancement and wall thickening of the
conduit. In 7 pts the "Matrix" valve conduit was replaced
by a homograft. Explants were evaluated through histo-
logical analysis that showed granulomatous inflamma-
tion and increased fibrous tissue content correlating with
CMR findings.
Conclusion
Conduit malfunction and paravalvular inflammation was
successfully detected with CMR in pts post implantation
of a decellularized pulmonary xenograft. As a conse-
quence of the devastating short term results, use of these
grafts was terminated at our center after initial use in 27
patients.
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